Quotes for Panion Animal Health AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Anja Holm
Chairperson of the Board
- Arne Ferstad
Board
- Jan Nilsson
- Lars Thunberg
Panion Animal Health is specialised in the development of gene therapy for the treatment of epilepsy in dogs and other pets. The products consist of a number of veterinary products and other forms of treatment. Today business is operated in Europe and North America. The company was established in 2005 as a subsidiary of CombiGene. The company is based in Hässleholm.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Combigene AB | 91,42 | 91,42 | 2019-09-30 |
Lars Thunberg | 11,90 | 11,90 | 2019-07-03 |
Patrik Kazimiersky | 5,83 | 5,83 | 2018-03-31 |
Avanza Pension | 0,54 | 0,54 | 2019-09-30 |
Anja Holm | 0,54 | 0,54 | 2018-06-04 |
Stefan Jonsson | 0,41 | 0,41 | 2019-09-30 |
Johan Sivander | 0,38 | 0,38 | 2019-09-30 |
Sofia Josephson | 0,27 | 0,27 | 2018-06-04 |
Lars Friis Mikkelsen | 0,26 | 0,26 | 2019-09-30 |
Henrik Amilon | 0,23 | 0,23 | 2019-09-30 |